Guan XQ, Wang CH, Cheng P, Fu LY, Wu QJ, Cheng G, . . . Sun ZJ. (2023). Effects of Empagliflozin on Gut Microbiota in Heart Failure with a Preserved Ejection Fraction: The Design of a Pragmatic Randomized, Open-Label Controlled Trial (EMPAGUM). Dove Medical Press.
Chicago Style (17th ed.) CitationGuan XQ, Wang CH, Cheng P, Fu LY, Wu QJ, Cheng G, Guan L, and Sun ZJ. Effects of Empagliflozin on Gut Microbiota in Heart Failure with a Preserved Ejection Fraction: The Design of a Pragmatic Randomized, Open-Label Controlled Trial (EMPAGUM). Dove Medical Press, 2023.
MLA (9th ed.) CitationGuan XQ, et al. Effects of Empagliflozin on Gut Microbiota in Heart Failure with a Preserved Ejection Fraction: The Design of a Pragmatic Randomized, Open-Label Controlled Trial (EMPAGUM). Dove Medical Press, 2023.